Investor Presentaiton

ESMO Highlights 2023 Agenda ESMO presentations ✓ TROPION-Lung01 study TLR ✓ TROPION-Lung05 Ph2 study results ✓ TROPION-Breast01 study TLR ✓ BEGONIA study longer follow-up data ✓ DESTINY-Pan Tumor02 primary analysis data ✓ DS-6000 Ph1 study OVC subgroup analysis data ✓ DS-7300 Ph1/2 study updated data (extract) 2 Q&A Speakers Ken Takeshita Head of Global R&D Daiichi-Sankyo Mark Rutstein Head of Global Oncology Clinical Development Content will be delivered on-demand after the meeting 3

View entire presentation